Application Information

This drug has been submitted to the FDA under the reference 076310/001.

Names and composition

"CABERGOLINE" is the commercial name of a drug composed of CABERGOLINE.
It belongs to the class Dopaminergics and is used in Parkinson's disease, parkinsonism (Central Nervous System)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
076310/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
077750/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
077843/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
078035/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
201503/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
202947/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020664/001 DOSTINEX CABERGOLINE TABLET/ORAL 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
076310/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
077750/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
077843/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
078035/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
201503/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG
202947/001 CABERGOLINE CABERGOLINE TABLET/ORAL 0.5MG

Manufacturers

Manufacturer name
Pfizer Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved